`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`DR. REDDY’S LABORATORIES, LTD. and
`DR. REDDY’S LABORATORIES, INC.
`Petitioner
`
`v.
`
`GALDERMA LABORATORIES, INC.
`Patent Owner
`
`U.S. Patent No. 8,603,506
`Issue Date: Dec. 10, 2013
`Title: Method of Treating Acne
`_______________
`
`Case IPR2015-01778
`_______________
`
`
`
`
`
`Patent Owner’s Mandatory Notices
`37 C.F.R. § 42.8
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`4813-3086-1096.1
`
`
`
`IPR2015-01778
`Patent 8,603,506
`
`
`Patent Owner Docket No. 105153-0104
`
`
`
` Patent Owner hereby files its Mandatory Notices under 37 C.F.R. § 42.8(a)(2).
`
`The Notices are being timely filed within 21 days of service of the Petition, which
`
`was served on Aug. 20, 2015.
`
`REAL PARTY-IN-INTEREST
`
`The real parties-in-interest for Patent Owner are Galderma Laboratories, Inc.
`
`and Nestle Skin Health S.A.
`
`RELATED MATTERS
`
`Patent Owner has asserted the ‘506 patent, as well as two related family
`
`members, U.S. Patent Nos. 7,211,267 (“the ‘267 patent”) and 7,232,572 (“the ‘572
`
`patent”), in a civil action filed in the United States District Court for the District of
`
`Delaware (Civil Action No. 15-670) on July 31, 2015 against Petitioner.
`
`The ‘267 and ‘572 patents were previously involved in a civil action filed by
`
`the Patent Owner in the United States District Court for the District of Delaware,
`
`including Research Foundation of State Univ. of N.Y. v. Mylan Pharms., Inc., No.
`
`09-cv-184-LPS (D. Del.); Research Foundation of State Univ. of N.Y. v. Lupin Ltd.
`
`et al., No. 09-cv-483-LPS (D. Del.); Research Foundation of State Univ. of N.Y. v.
`
`Impax Labs. Inc., No. 09-cv-703-LPS (D. Del.); Research Foundation of State
`
`Univ. of N.Y. v. Sandoz Inc., No. 11-cv-162-LPS (D. Del.); and Galderma
`
`Laboratories Inc. et al. v. Amneal Pharms. LLC et al., No. 11-cv-1106-LPS (D.
`
`4813-3086-1096.1
`
`2
`
`
`
`IPR2015-01778
`Patent 8,603,506
`
`
`Patent Owner Docket No. 105153-0104
`
`
`
`Del.). The Mylan Pharmaceuticals, Impax Laboratories, and Lupin
`
`Pharmaceuticals cases were appealed to the Court of Appeals for the Federal
`
`Circuit (No. 2012-1523 et seq.).
`
`Apart from the captioned petition, Petitioner concurrently filed two other
`
`petitions for inter partes review of the same claims of the ‘506 patent, which
`
`petitions have been assigned nos. IPR2015-01777 and IPR2015-01782.
`
`Lastly, a continuation application (Ser. No. 14/753,544) claiming priority to
`
`the ‘506 patent is currently pending.
`
`LEAD AND BACKUP COUNSEL
`
`Lead Counsel:
`
`Stephen B. Maebius
`Foley & Lardner LLP
`3000 K St., NW., Suite 600
`Washington, DC 20007
`Direct Line: 202-672-5569
`Email: smaebius@foley.com
`Fax: 202-672-5399
`USPTO Reg. No. 35,264
`
`Backup Counsel:
`
`Sunit Talapatra
`Foley & Lardner LLP
`3000 K St., NW., Suite 600
`Washington, DC 20007
`Direct Line: 202-295-4621
`Email: stalapatra@foley.com
`Fax: 202-672-5399
`
`
`
`4813-3086-1096.1
`
`3
`
`
`
`IPR2015-01778
`Patent 8,603,506
`
`
`Patent Owner Docket No. 105153-0104
`
`
`
`USPTO Reg. No. 54,482
`
`Michael Houston
`Foley & Lardner LLP
`321 N. Clark St., Suite 2800
`Chicago, IL 60654
`Direct Line: 312-832-4378
`Email: mhouston@foley.com
`Fax: 312-832-4700
`USPTO Reg. No. 58,486
`
`Gerald J. Flattmann, Jr.
`Paul Hastings LLP
`75 East 55th Street
`New York, NY 10022
`Direct line: 212-318-6720
`Email: geraldflattmann@paulhastings.com
`Fax: 212-230-7720
`USPTO Reg. No. 37,324
`
`
`
`
`
`4813-3086-1096.1
`
`4
`
`
`
`IPR2015-01778
`Patent 8,603,506
`
`
`Patent Owner Docket No. 105153-0104
`
`
`
`SERVICE INFORMATION
`
`Please address all correspondence to the lead counsel at the address shown
`
`above and to the lead and backup counsel by email at: smaebius@foley.com,
`
`stalapatra@foley.com, mhouston@foley.com, and
`
`geraldflattmann@paulhastings.com. Patent Owner consents to electronic service
`
`by e-mail at the e-mail addresses shown above.
`
`Date: September 9, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Stephen B. Maebius/
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`4813-3086-1096.1
`
`5
`
`
`
`IPR2015-01782
`Patent 8,603,506
`
`
`Attorney Docket No. 105153-0104
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner’s Mandatory Notices was served on counsel of record on September 9,
`
`2015 by filing this document through the Patent Review Processing System as well
`
`as delivering a copy via email to the counsel of record for the Petitioner at the
`
`following addresses: WMentlik.ipr@ldlkm.com, MTeschner.ipr@ldlkm.com,
`
`BTomkins.ipr@ldlkm.com, and MFuller.ipr@ldlkm.com.
`
`
`
`
`
`
`
`
`
`
`/Stephen B. Maebius/
`
`Stephen B. Maebius
`Registration No. 35,264
`Counsel for Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Date: September 9, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`4813-3086-1096.1